At close: January 3 at 4:00:02 PM EST
After hours: January 3 at 7:58:38 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -0.16 | 0 | -0.61 | -0.35 |
Low Estimate | -0.16 | 0 | -0.61 | -0.35 |
High Estimate | -0.16 | 0 | -0.61 | -0.35 |
Year Ago EPS | -0.71 | -0.46 | -6 | -0.61 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -1.34 | -0.22 | -0.14 | -0.13 |
EPS Actual | -0.71 | -0.46 | -0.24 | -0.04 |
Difference | 0.63 | -0.24 | -0.1 | 0.09 |
Surprise % | 47.01% | -109.09% | -71.43% | 69.23% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.16 | 0 | -0.61 | -0.35 |
7 Days Ago | -0.16 | 0 | -0.61 | -0.35 |
30 Days Ago | -0.16 | 0 | -0.61 | -0.35 |
60 Days Ago | -0.16 | 0 | -0.61 | -0.35 |
90 Days Ago | -0.16 | 0 | -0.61 | -0.35 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | -- | 1 | 1 |
Up Last 30 Days | 1 | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MBIO | 77.46% | -- | 89.83% | 42.62% |
S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/16/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/24/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2023 |
Maintains | BTIG: Buy to Buy | 8/15/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Related Tickers
BLRX BioLineRx Ltd.
0.2738
+7.12%
ONCO Onconetix, Inc.
0.8097
+24.36%
VINC Vincerx Pharma, Inc.
0.2305
-2.04%
SCPX Scorpius Holdings, Inc.
0.5507
+59.48%
APM Aptorum Group Limited
2.1400
-2.73%
EYEN Eyenovia, Inc.
0.1101
-8.25%
REVB Revelation Biosciences, Inc.
0.6470
-1.52%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4600
+24.02%
VSTM Verastem, Inc.
7.00
+7.86%
NMRA Neumora Therapeutics, Inc.
2.1700
+10.15%